Larry Tsai

Larry Tsai is an accomplished medical professional with extensive experience in respiratory, allergy, and infectious disease product development. Currently serving as the Vice President and Global Head of Respiratory, Allergy, and Infectious Disease Product Development at Genentech since June 2019, previous roles include leadership positions in multiple companies, such as Chief Medical Officer at Tetraphase Pharmaceuticals and Staff Physician at Brigham and Women's Hospital. Larry Tsai's expertise includes managing clinical development teams, overseeing late-stage drug candidate development, and conducting pivotal studies. Educational credentials include fellowships in Pulmonary and Critical Care Medicine from Harvard Medical School and the University of California, San Francisco, as well as a Doctor of Medicine degree from Harvard Medical School and a Bachelor of Science degree from Stanford University.